Stock listing
TWSE:4155 OK Biotech Co., Ltd. (訊映) 股價
Follow OK Biotech Co., Ltd. into a list and get an email when it puts out news.
Share price · TWSE:4155
$15.50 TWD -2.45 (-13.6%)
Close on Nov 20, 2026
- Day range
- $15.20 – $16.00 TWDNov 20, 2026
- Volume
- 1.60M sharesNov 20, 2026
- Market cap
- $1.82B TWDAt the close on Nov 20, 2026 · price × 117.2M shares outstanding
- 52-week range
- $14.34 – $19.30 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $11.85M TWDMedian day 248,123 shares · 4 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:4155 · TWD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $15.50 | -2.45 | -13.6% | $15.50 | $16.00 | $15.20 | 1,601,324 | |
| $17.95 | -0.60 | -3.2% | $18.55 | $18.55 | $17.10 | 2,172,125 | |
| $18.55 | +1.00 | +5.7% | $17.55 | $19.30 | $16.90 | 3,648,122 | |
| $17.55 | +0.20 | +1.2% | $18.25 | $18.85 | $17.55 | 1,822,369 | |
| $17.35 | +0.65 | +3.9% | $16.90 | $18.30 | $16.90 | 1,435,210 | |
| $16.70 | -0.20 | -1.2% | $17.10 | $17.40 | $16.60 | 586,411 | |
| $16.90 | -0.60 | -3.4% | $17.25 | $17.95 | $16.50 | 1,188,733 | |
| $17.50 | -1.00 | -5.4% | $17.80 | $18.65 | $17.25 | 1,508,723 | |
| $18.50 | +0.60 | +3.4% | $18.50 | $18.85 | $17.65 | 2,752,445 | |
| $17.90 | +1.55 | +9.5% | $15.65 | $17.90 | $15.25 | 1,473,452 | |
| $16.35 | -0.45 | -2.7% | $16.80 | $17.05 | $16.30 | 764,230 | |
| $16.80 | +0.15 | +0.9% | $16.80 | $16.85 | $16.35 | 335,249 | |
| $16.65 | -0.65 | -3.8% | $17.25 | $17.30 | $16.30 | 752,115 | |
| $17.30 | +0.50 | +3.0% | $16.15 | $17.45 | $16.15 | 868,222 | |
| $16.80 | -0.25 | -1.5% | $17.05 | $17.40 | $16.75 | 615,921 | |
| $17.05 | +0.65 | +4.0% | $16.40 | $17.45 | $16.25 | 1,089,328 | |
| $16.40 | -0.10 | -0.6% | $16.50 | $16.75 | $16.30 | 453,005 | |
| $16.50 | -0.30 | -1.8% | $16.60 | $17.05 | $16.20 | 840,113 | |
| $16.80 | 0.00 | 0.0% | $16.80 | $16.80 | $16.80 | 0 | |
| $16.80 | -0.40 | -2.3% | $17.50 | $17.55 | $16.75 | 1,284,254 | |
| $17.20 | +1.05 | +6.5% | $16.00 | $17.75 | $15.45 | 3,429,787 | |
| $16.15 | +0.05 | +0.3% | $16.60 | $17.35 | $16.10 | 3,792,863 | |
| $16.10 | +0.257 | +1.6% | $15.15 | $16.10 | $15.15 | 1,328,477 | |
| $15.84 | 0.00 | 0.0% | $15.84 | $15.84 | $15.84 | 0 | |
| $15.84 | 0.00 | 0.0% | $15.84 | $15.84 | $15.84 | 0 | |
| $15.84 | 0.00 | 0.0% | $15.84 | $15.84 | $15.84 | 0 | |
| $15.84 | -0.614 | -3.7% | $16.46 | $16.57 | $15.84 | 464,337 | |
| $16.46 | -0.112 | -0.7% | $16.57 | $16.68 | $16.40 | 178,692 | |
| $16.57 | 0.00 | 0.0% | $16.40 | $16.68 | $16.40 | 98,369 | |
| $16.57 | +0.223 | +1.4% | $16.46 | $16.57 | $16.29 | 245,905 | |
| $16.34 | +0.056 | +0.3% | $16.29 | $16.40 | $16.23 | 148,347 | |
| $16.29 | -0.279 | -1.7% | $16.57 | $16.57 | $16.29 | 135,188 | |
| $16.57 | +0.167 | +1.0% | $16.40 | $16.85 | $16.40 | 163,512 | |
| $16.40 | -0.167 | -1.0% | $16.57 | $16.74 | $16.29 | 277,346 | |
| $16.57 | -0.056 | -0.3% | $16.74 | $16.74 | $16.46 | 162,457 | |
| $16.62 | -0.279 | -1.7% | $16.90 | $16.96 | $16.62 | 137,880 | |
| $16.90 | +0.335 | +2.0% | $16.57 | $16.90 | $16.57 | 316,135 | |
| $16.57 | 0.00 | 0.0% | $16.51 | $16.62 | $16.40 | 138,314 | |
| $16.57 | +0.167 | +1.0% | $16.46 | $16.68 | $16.29 | 121,822 | |
| $16.40 | 0.00 | 0.0% | $16.34 | $16.46 | $16.29 | 65,073 | |
| $16.40 | -0.502 | -3.0% | $16.85 | $16.85 | $16.18 | 341,464 | |
| $16.90 | +0.39 | +2.4% | $16.46 | $16.90 | $16.34 | 314,904 | |
| $16.51 | +0.781 | +5.0% | $16.18 | $17.18 | $16.18 | 989,950 | |
| $15.73 | -0.056 | -0.4% | $15.84 | $15.84 | $15.62 | 187,072 | |
| $15.79 | -0.167 | -1.0% | $15.95 | $15.95 | $15.79 | 72,061 | |
| $15.95 | -0.167 | -1.0% | $16.01 | $16.23 | $15.84 | 205,008 | |
| $16.12 | +0.167 | +1.0% | $15.95 | $16.12 | $15.84 | 206,725 | |
| $15.95 | -0.112 | -0.7% | $16.12 | $16.12 | $15.90 | 124,456 | |
| $16.07 | -0.112 | -0.7% | $16.18 | $16.18 | $15.79 | 249,873 | |
| $16.18 | -0.056 | -0.3% | $16.23 | $16.34 | $16.12 | 102,977 | |
| $16.23 | +0.112 | +0.7% | $16.07 | $16.29 | $16.07 | 108,221 | |
| $16.12 | -0.056 | -0.3% | $16.18 | $16.23 | $16.07 | 84,668 | |
| $16.18 | -0.056 | -0.3% | $16.18 | $16.23 | $16.01 | 151,374 | |
| $16.23 | +0.056 | +0.3% | $16.18 | $16.29 | $16.07 | 116,350 | |
| $16.18 | +0.056 | +0.3% | $16.12 | $16.18 | $16.01 | 70,257 | |
| $16.12 | -0.335 | -2.0% | $16.51 | $16.51 | $16.07 | 246,372 | |
| $16.46 | -0.112 | -0.7% | $16.46 | $16.51 | $16.34 | 146,349 | |
| $16.57 | +0.223 | +1.4% | $16.29 | $16.57 | $16.29 | 120,139 |
Splits
4 splits since 2014 · TWSE:4155 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-1.1157 | Consolidation | |
| 54-for-49 | Split | |
| 101-for-84 | Split | |
| 13-for-10 | Split |
- Ticker
- TWSE:4155
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- TWSE
- Currency
- TWD
What changed lately
Latest news release · Jun 9, 2026
Table: OK Biotech May Rev NT$139.2M Vs NT$143.5M
Latest news
Table: OK Biotech May Rev NT$139.2M Vs NT$143.5M
Jun 9, 2026
Closed $16.62 (-0.7%) on Jun 9, 2026
Table: OK Biotech Apr Rev NT$127.2M Vs NT$140.4M
May 8, 2026
Closed $14.45 (-0.8%) on May 11, 2026
Table: OK Biotech Mar Rev NT$146.2M Vs NT$163.2M
Apr 9, 2026
Closed $14.56 (-0.8%) on Apr 9, 2026
OK Biotech Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 3 in the last 12 months · 3 in all · newest Jun 9, 2026 · oldest 2026
- Decks
- 1 deck · latest Sep 17, 2020
Valuation
P/E 7.5× against a median of 12.1×: 3rd lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.48B TWD
- P/E
- 7.5×
- EV/sales
- 1.6×
- EV/EBITDA
- 7.9×
- Price/book
- 0.7×
- Gross margin
- 31.1%
- Operating margin
- 14.3%
- Net margin
- 15.8%
- Debt to equity
- 0.4×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| OK Biotech Co., Ltd. · TWSE:4155 | US$55.10M | US$75.16M | 7.5× | 1.6× | 7.9× | 0.7× | 15.8% | 0.4× | n/a |
| Vincent Medical Holdings Limited · HKEX:1612 | US$57.26M | US$62.46M | 4.3× | 0.5× | 2.9× | 0.6× | 11.2% | 0.3× | n/a |
| REMED Co., Ltd. · KRX:302550 | US$57.14M | US$51.29M | 37.5× | 2.5× | 20.4× | 2.0× | 7.6% | 0.1× | n/a |
| Enzymatica AB · OMXSTO:ENZY | US$55.08M | US$55.77M | n/a | 11.1× | n/a | 6.0× | −80.5% | 0.1× | n/a |
| LENSAR, Inc. · NASDAQ:LNSR | US$54.83M | US$44.40M | 1.6× | 0.7× | 18.0× | 5.0× | 56.1% | 0.2× | 0.76 |
| P&S Robotics Co., Ltd. · KRX:460940 | US$54.38M | US$33.62M | 26.6× | 5.9× | 36.6× | 1.7× | 36.0% | 0.0× | n/a |
| Creo Medical Group PLC · LSE:CREO | US$54.06M | US$49.48M | 7.8× | 6.3× | n/a | 0.9× | 88.3% | 0.1× | n/a |
| Crystalvue Medical Co Ltd · TPEX:6527 | US$53.82M | US$52.19M | 12.1× | 1.8× | 8.7× | 1.7× | 15.5% | 0.0× | n/a |
| 3D Global Biotech Inc. · TPEX:6808 | US$53.26M | US$38.17M | 26.4× | 6.1× | 17.5× | 2.4× | 32.2% | 0.0× | n/a |
| Outset Medical, Inc. · NASDAQ:OM | US$53.03M | US$14.77M | n/a | 0.1× | n/a | 0.6× | −58.3% | 1.2× | 1.74 |
| NeurAxis, Inc. · AMEX:NRXS | US$52.99M | US$48.80M | n/a | 7.5× | n/a | 14.6× | −185.2% | 0.1× | 1.77 |
| Median of the others | US$54.22M | US$49.14M | 12.1× | 4.2× | 17.8× | 1.9× | 13.3% | 0.1× | 1.74 |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | May 11, 2023 · After close | +1.2% |
| Q4 2022 | Mar 9, 2023 · Before open | −0.6% |
| Q3 2022 | Nov 9, 2022 · Before open | +1.2% |
| Q2 2022 | Aug 10, 2022 · Before open | −1.5% |
| Q1 2022 | May 11, 2022 · Before open | −0.9% |
| Q4 2021 | Mar 9, 2022 · After close | +1.1% |
| Q3 2021 | Nov 11, 2021 · Before open | 0.0% |
| Quarter to Jun 30, 2021 | Aug 15, 2021 · After close | −1.1% |
| Quarter to Mar 31, 2021 | May 12, 2021 · Before open | −2.6% |
| Quarter to Dec 31, 2020 | Mar 31, 2021 · Before open | −0.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2020) | Investor deck | 13 slides | Sep 17, 2020 |
Financials
Annual, in TWD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.56B | 1.67B | 1.19B | 1.48B | 1.26B | 1.48B | 1.24B | 1.12B | 1.23B | 1.04B |
| Cost of revenue | 1.13B | 1.39B | 995.1M | 1.14B | 1.08B | 1.16B | 945.1M | 818.2M | 945.0M | 829.9M |
| Gross profit | 429.3M | 275.7M | 196.9M | 345.0M | 186.8M | 326.0M | 296.1M | 302.1M | 288.1M | 210.6M |
| Research and development | 59.0M | 57.9M | 46.7M | 48.7M | 28.7M | 45.5M | 32.6M | 40.8M | 32.6M | 20.2M |
| Selling, general and administrative | 159.6M | 98.9M | 73.9M | 68.5M | 62.7M | 72.1M | 76.1M | 70.3M | 68.2M | 58.0M |
| Operating income | 107.9M | 57.2M | -12.1M | 211.6M | 49.3M | 170.1M | 147.5M | 141.7M | 130.6M | 108.0M |
| Depreciation and amortization | 93.6M | 72.4M | 75.5M | 67.9M | 55.9M | 50.1M | 41.6M | 30.3M | 23.4M | 25.5M |
| EBITDA | 201.5M | 129.6M | 63.5M | 279.5M | 105.2M | 220.2M | 189.0M | 172.0M | 154.0M | 133.5M |
| Interest expense | 10.9M | 6.23M | 9.00M | 11.4M | 8.08M | 8.12M | 6.12M | 5.30M | 4.02M | 3.58M |
| Income before tax | 103.9M | 127.1M | 8.03M | 175.6M | 46.1M | 151.7M | 143.4M | 201.6M | 163.2M | 132.6M |
| Income tax | 6.74M | 20.8M | 9.62M | 38.9M | 14.7M | 30.4M | 30.7M | 41.1M | 36.4M | 47.4M |
| Net income | 82.4M | 94.0M | 2.95M | 143.5M | 31.4M | 129.7M | 125.8M | 161.4M | 126.8M | 85.2M |
| Earnings per share, basic | 0.49 | 0.64 | 0.02 | 1.08 | 0.26 | 1.28 | 1.41 | 2.04 | 1.82 | 1.25 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 314.5M | 277.5M | 323.0M | 596.4M | 599.9M | 566.7M | 332.3M | 184.4M | 455.7M | 164.3M |
| Short-term investments | 12.6M | 13.0M | 42.3M | 40.2M | 44.8M | |||||
| Receivables | 409.8M | 571.5M | 488.6M | 409.5M | 404.9M | 306.1M | 290.5M | 259.6M | 209.0M | 222.2M |
| Inventory | 456.0M | 530.5M | 394.0M | 422.9M | 375.6M | 349.1M | 365.4M | 272.5M | 182.8M | 162.0M |
| Current assets | 1.25B | 1.47B | 1.32B | 1.53B | 1.49B | 1.28B | 1.04B | 802.8M | 887.0M | 571.2M |
| Property, plant and equipment | 874.7M | 659.4M | 606.0M | 553.2M | 517.3M | 515.8M | 446.7M | |||
| Goodwill | 353.5M | 353.5M | 23.6M | 23.6M | 29.6M | 29.6M | 29.6M | 28.8M | ||
| Total assets | 3.85B | 3.70B | 3.07B | 3.06B | 2.81B | 2.54B | 2.22B | 1.85B | 1.88B | 1.50B |
| Accounts payable | 116.4M | 195.4M | 199.1M | 244.6M | 238.5M | 205.7M | 217.1M | 197.3M | 146.6M | 182.9M |
| Current liabilities | 547.6M | 744.8M | 578.1M | 828.2M | 700.6M | 653.4M | 603.2M | 325.1M | 482.7M | 318.6M |
| Long-term debt | 606.5M | 322.0M | 91.9M | 383.0M | 401.8M | 123.9M | 280.6M | 255.7M | 195.4M | 232.0M |
| Total debt | 1.03B | 779.4M | 333.0M | 780.6M | 735.7M | 305.3M | 534.1M | 258.8M | 386.0M | 291.0M |
| Total liabilities | 1.27B | 1.13B | 672.3M | 1.21B | 1.11B | 795.9M | 918.4M | 582.7M | 678.1M | 550.6M |
| Shareholders' equity | 2.51B | 2.49B | 2.40B | 1.84B | 1.70B | 1.73B | 1.29B | 1.25B | 1.21B | 944.8M |
| Shares outstanding | 167.5M | 146.4M | 128.4M | 132.4M | 120.4M | 101.3M | 89.3M | 79.0M | 69.7M | 68.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 319.6M | 65.9M | 2.93M | 240.5M | 21.9M | 147.7M | 45.2M | 128.8M | 102.8M | 260.7M |
| Capital spending | -409.1M | -374.7M | -437.1M | -294.2M | -86.5M | -79.8M | -78.0M | -28.4M | -88.0M | -57.0M |
| Free cash flow | -89.6M | -308.8M | -434.1M | -53.7M | -64.6M | 67.9M | -32.8M | 100.4M | 14.7M | 203.7M |
| Cash from investing | -398.5M | -444.9M | -358.4M | -294.2M | -174.5M | -127.0M | -85.5M | -62.2M | -96.6M | -67.6M |
| Cash from financing | 113.0M | 338.0M | 82.1M | 50.3M | 185.7M | 215.8M | 185.1M | -337.9M | 285.2M | -104.1M |
| Dividends paid | -43.8M | -44.1M | -144.6M | -94.9M | -131.8M | -112.1M | -166.4M | -111.3M | -100.4M | -100.2M |
| Share buybacks | -33.3M | 0 | 2.55B | -5.73M | -39.6M | 0 | 0 | |||
| Change in cash | 37.0M | -45.6M | -273.4M | -3.44M | 33.1M | 234.4M | 147.9M | -271.3M | 291.4M | 88.6M |
Cap table
Built by 6ix from OK Biotech Co., Ltd.’s releases
- Common shares
- 117,162,283
- Fully diluted
- 117,162,283
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 117,162,283 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 117,162,283 |
Log in to ask 6ix AI your own questions about OK Biotech Co., Ltd.